Anti-Atherogenic Role of Peroxisome Proliferator-Activated Receptor Ligands

Publisher： Bentham Science Publishers

E-ISSN： 1875-6557|1|2|89-102

ISSN： 1573-403X

Source： Current Cardiology Reviews, Vol.1, Iss.2, 2005-06, pp. : 89-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptor- in macrophage lipid homeostasis

By Lee C.-H.   Evans R.M.  

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 8, 2002-10 ,pp. : 331-335

Elsevier

Access to resources Recommend Favorite

Peroxisome Proliferator Activated Receptor-γ (PPAR-γ) Ligands and Angiogenesis

By Margeli A.   Kouraklis G.   Theocharis S.  

Angiogenesis, Vol. 6, Iss. 3, 2003-01 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

A Potential Role of Diet in Modulating Peroxisome Proliferator-Activated Receptor (PPAR)-Mediated Signalling in Arthritis

By  

Current Rheumatology Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 246-251

Bentham Science Publishers

Access to resources Recommend Favorite

Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers

By  

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 106-112

Karger

Access to resources Recommend Favorite